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Synthetic anticancer drugs are expensive and toxic; therefore, there has been much interest in developing anticancer agents from 
natural resources and especially plants. The stem bark of Adansonia digitata (SBAD) has many traditional medicinal uses, 
including the treatment of cancer, but there is currently little scientific evidence to support this. The aim of this study was 
therefore to assess the cytotoxic and long term antiproliferative effects of a methanol extract of SBAD (MESBAD) in breast 
cancer cells. Cold extraction was done on SBAD using 70% methanol for 72 hrs. The extract was filtered, concentrated and 
lyophilized. MCF-7 breast cancer cells were cultured using an established procedure and were treated with MESBAD or DMSO 
as control. Cytotoxicity and long-term survival were measured using MTT and clonogenic assays respectively. Western blotting 
was performed with antibodies against p53 and p21. MESBAD induced short-term and long-term (13 to 15 days) cytotoxicity in 
breast cancer cells in a dose dependent manner and exhibited an IC50 of 100μM. Western blotting indicated that MESBAD 
activated the p53 tumour suppressor and its target, p21. MESBAD induces cytotoxicity and inhibits long-term survival of MCF-
7 breast cancers cells through a mechanism involving the up-regulation of the cell cycle and cell death regulators p53 and p21. 
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INTRODUCTION 
 
Cancer is, for the most part, an age-related disease for which 
there is still an ongoing search for more effective treatment. In 
Nigeria, about 100,000 new cases are reported each year with 
breast cancer taking the lead (Adebamowo and Ajayi, 2000).  
 Natural products play important roles in the treatment and 
management of various ailments including cancers. The 
search for potent anticancer agents from indigenous plant 
origin is therefore of interest. This is particularly important 
because of the toxicity and high cost associated with synthetic 
drugs which limits their access to developing and 
underdeveloped countries.  
 Adansonia digitata (Linn) belongs to the family 
Bombacaceae and is commonly known as Baobab, Cream of 
Tartar Tree, Monkey Bread Tree and Lemonade Tree. It is 
usually found in the savanna region, but it tolerates a wide 
range of climate conditions (Keay, 1989). Traditional uses of 
Adansonia digitata for nutritional and various medicinal 
purposes have been reported (Chadare et al., 2009). These 
medicinal uses include: treatment of intestinal and skin 
disorders, anti-inflammatory, antipyretic and analgesic 
(Shukla et al., 2001; Wickens, 1979; Sibibe and Williams, 
2002; Ramadan et al., 1994; Palombo, 2006; Ajose, 2007). 
The stem bark has been shown to have antibacterial activity 
(Yeshua’u et al., 2010), hypoglycemic activity (Tanko et al., 
2008). The antibacterial, antiviral and anti-trypanosomal 
effects of the extracts of this plant have also been reported 
(Anani et al., 2000; Hudson et al., 2000; Atawodi et al., 2003; 
Vimalanathan and Hudson, 2009). The stem bark possesses 
the alkaloid “Adansonin” with strophanthus-like action, which 
is thought to be the active component for treating malaria and 
other fevers, especially in Africa and other parts of the tropics 
(Sibibe and Williams, 2002; Wickens and Lowe, 2008). There 
are also reported evidences that extracts of Adansonia digitata 




Methanol extract of Adansonia digitata Linn is cytotoxic in breast cancer cells 
124 Afr. J. Biomed. Res. Vol. 24, No.1 (January) 2021  Adegoke, Prince & Odunola 
(2013) reported the antitumor effects of the extracts of seeds 
and fruit pulp of Adansonia digitata on ehrlich ascites 
carcinoma. A Report from Guinea revealed that baobab fruit 
extract possesses antitumor activities (Kerharo and Adam 
1974; Jackson 2015).  
 There is still very limited information in the literature 
about the anticancer activities associated with the stem bark of 
Adansonia digitata (SBAD). This study was therefore 
designed to investigate the cytotoxic and antiproliferative 
activities of the methanol extract of SBAD (MESBAD) on 
oestrogen receptor positive human breast adenocarcinoma 
MCF-7 cells. 
 
MATERIALS AND METHODS 
 
Collection, Identification and Authentication of Plant 
materials: Samples used for this study were obtained from 
Ajibode extension of the University of Ibadan, Oyo State, 
Nigeria. Fresh leaves and fruits of the tree were used for its 
identification/authentication. The plant was identified by Mr. 
Esimekhuai Donatus, a taxonomist of the Department of 
Botany, University of Ibadan, and authenticated at the 
herbarium of Forestry Research Institute, Jericho, Ibadan 
Nigeria, with FHI NO. 109859.  
 
Preparation of Methanol stem bark Extract of Adansonia 
digitata L: Fresh stem bark of the plant was harvested and 
dried at ambient room temperature to obtain a fixed weight. 
The dried stem bark was finely milled and extracted with 70% 
methanol for 72 hours at room temperature. The methanol 
extract was concentrated in a rotary evaporator at 40 0C, 
lyophilized and preserved until required for use. 
 
Cells and culture: The oestrogen receptor positive human 
breast adenocarcinoma MCF-7 cells (obtained from the 
Department of Human Biology, University of Cape Town 
Medical School, Cape Town, South Africa) were maintained 
according to the protocols described by Celis, (1998) and 
Freshney, (2000). The cells were maintained in RPMI 1640 
(Highveld Biological, Lyndhurst, UK) supplemented with 
10% foetal bovine serum (FBS), 100 U/ml penicillin and 100 
μg/mL streptomycin and incubated at 37 °C in a 5% CO2, 95% 
air-humidified incubator. For maintenance, cultures were 
passaged weekly, and the culture medium was changed twice 
a week. The monolayer cells were detached with trypsin - 
ethylenediamine tetraacetic acid (EDTA) to make single cell 
suspensions and viable cells were counted using a 
hemocytometer and diluted with medium containing 5% FBS 
to give final density of 1x105 cells/ml. Cells were seeded into 
96-well plates at a density of 10,000 cells/well and incubated 
for at least 48 hrs to allow for cell attachment before further 
experiments were performed.  
 
Cell Viability: Cell viability was assessed by the trypan blue 
dye exclusion method (Rosengard and Cochrane, 1983). Cells 
numbers were calculated as follows: cells per mL = N x 5 x 
D.F. / volume, where, N is the total number of cells counted in 
5 squares, D.F. is the dilution factor and volume is the depth of 
the counting chamber (0.1 mm3 = 1x10-4). Therefore, cells / ml 
= N x 5 x D.F. x 104. Dilution factor was calculated by dividing 
the total volume used (20 µL) with the cell suspension volume 
(10 µL). The percentage cell viability was determined as 
follows: Viable cells x 100 / Total number of cells. 
 
Cytotoxicity Study: Cells were plated to 70% confluency in 
96 well plates. After 24 hrs the cells were treated with serial 
concentrations of MESBAD in triplicate. MESBAD was 
initially dissolved in dimethylsulfoxide (DMSO) and diluted to 
the desired final test concentrations of 50, 100, 250, 500 and 
1000 μg/mL with medium and the mixture was filter-sterilized 
using 0.22µm syringe filter unit (Millipore, USA).  Following 
drug addition, the plates were incubated for an additional 48 
hrs at 37 °C, 5 % CO2, 95 % air and 100% relative humidity. 
After 48 hrs of incubation, 15 μL of MTT (3-[4, 5-dimethyl 
thiazole-2-yl]-2, 5-diphenyl-tetrazolium bromide) (Roche, 
USA) (5mg/mL) was added to each well and incubated at 37 
°C for 4 hrs. The medium with MTT was then flicked off and 
the formazan crystals formed were solubilized in 100 μL 
solubilizing solution and the absorbance measured at585 nm 
using a microplate reader. At least three biological repeats 
were conducted to determine the IC50 concentrations. The 
mean cell viability was calculated as a percentage of the mean 
vehicle control (Mosmann, 1983). The percentage cell 
inhibition was thereafter determined as follows: nonlinear 
regression graphs were plotted between percentage cell 
inhibition and Log 10 concentration and IC50 was determined 
using GraphPad Prism software. The percent inhibition was 
calculated using the following formula: 
% inhibition = 100 - (mean of Absorbance of sample/mean of 
Absorbance of control) × 100 
 
Clonogenic survival study: The clonogenic or colony 
formation assay is a widely used method to study the number 
and size of cancer cell colonies that remain after irradiation or 
the administration of cytotoxic agents and serves as a measure 
of the long-term anti-proliferative effect of these treatments. 
MCF-7 cells were treated with the IC50 and 2xIC50 
concentrations of MESBAD for 24 hrs, washed, collected and 
re-plated at 1000 cells per well in MESBAD-free medium in 
6-well plates. Cells were allowed to grow for 14 days with 
regular changes of medium, until the cells in the control plates 
formed colonies (50 cells per colony is the minimum for 
scoring) and surviving cells were fixed and stained with crystal 
violet (Sigma-Aldrich, USA). The numbers of colonies were 
thereafter evaluated according to Aliwaini et al. (2013). 
 
Western blot analysis: MCF-7 cells were harvested, and 
protein prepared as previously described by Aliwaini et al. 
(2013). Equal amounts of protein were loaded in each lane and 
resolved on 8 % and 15 % SDS-PAGE gels and then 
transferred by electrophoresis to Hybond ECL nitrocellulose 
membranes (Amersham Biosciences, USA). Membranes were 
blocked for 1 hr at room temperature with PBS containing 5 % 
non-fat dry milk and probed with appropriate primary 
antibodies at 4 °C with shaking. Membranes were washed in 
PBS containing 0.1% Tween 20 (PBS/T) and incubated with 
either goat anti-mouse or goat anti-rabbit IgG peroxidase-
conjugated secondary antibodies (1:5000) (BioRad, Hercules, 
CA, USA) in blocking solution at room temperature with 
shaking for 1 hr. Membranes were again washed in PBS/T and 
Methanol extract of Adansonia digitata Linn is cytotoxic in breast cancer cells 
125 Afr. J. Biomed. Res. Vol. 24, No.1 (January) 2021  Adegoke, Prince & Odunola 
visualised by enhanced chemiluminescence (Pierce, USA). 
Primary antibodies used were anti-p53 (sc-126), anti-p21 (sc-
756) and anti-p38 (M0800) (Sigma, St. Louis, MO, USA). 
 
Statistical analysis 
Data presented are mean ± SEM (standard error of the means) 
of three independent experiments and a value of p < 0.05 was 
accepted as statistically significant. One-way ANOVA was 
used to compare means of more than two samples/groups and 
the t test was used to compare two samples/groups. 
 
RESULTS 
The cytotoxic effect of MESBAD on the human breast 
adenocarcinoma MCF-7 cells was examined using the MTT 
assay. After 48 hrs of MESBAD treatment, a dose dependent 
cytotoxicity was observed and an IC50 of 100 μM was obtained 
(Fig. 1). The result shows that MESBAD exerts potent 
cytotoxic activity against MCF-7 cells. Furthermore, MCF-7 
cells were treated with MESBAD and the effect on long-term 
proliferation of MCF-7 cells was assessed using clonogenic 
survival assays. The results presented in figures 2a and 2b 
show that MESBAD caused a clear reduction in the 
proliferation of MCF-7 cells when compared with the control 
cells treated with DMSO. Furthermore, the antiproliferative 
activity of MESBAD is dose dependent as seen in the number 
of colonies present in the cells treated with ½ IC50 and IC50 
(Fig. 2a). In order to validate this activity, multiples of the IC50 
were used to assess the possibility of complete disappearance 
of colonies of the cells. The results obtained presented a 
similar pattern with the earlier result; the plates with the cells 
treated with 4xIC50 have very scanty colonies (Fig. 2b).  
 
 
Figure 1:  
Cytotoxic effect of MESBAD on MCF-7 cells using MTT assay. a 
means is a significant difference (p < 0.05) when compared with the 




Figure 2a:  




Figure 2b:  
Antiproliferative and inhibitory effect of MESBAD on MCF-7 cells using the clonogenic assay at IC50, 2xIC50 and 4xIC50 of MESBAD 
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Figure 4:  
p21 protein probe with 5% box milk PBS/T (MCF-7). MESBAD induces p21 activation in a concentration dependent manner. Lane 1 was 
designated as vehicle control (0.1% DMSO), 2. 2xIC50(24hrs), 3. 2xIC50(48hrs), 4. 4xIC50(24hrs), 5. 4xIC50(48hrs), 6. 1/2IC50(24hs) 7. 
1/2IC50(48hs) 8.  IC50(24hs) 9. IC50(48hs) Western blotting of protein from MESBAD treated breast cancer cells shows the levels of p53 (Figure 
3) and p21 (Figure 4) and total p38 were used as loading controls. The expression of the proteins were quantified and normalised to p38 levels. 
 
Therefore, the higher the concentration, the higher the 
antiproliferative activity induced by MESBAD. These data 
demonstrate that at the concentrations tested, MESBAD has 
potent cytotoxic and anti-survival/antiproliferative effects on 
MCF-7 cells. The tumour suppressor p53 and its target gene 
p21 play critical roles in regulating cell cycle progression and 
cell death and thus we decided to look at the effects of 
MESBAD on these proteins in order to predict the mechanism 
of cytotoxicity of MESBAD. Fig. 3 shows that p53 levels were 
markedly up-regulated at 24 and 48 hrs in the 2xIC50 treated 
cells, while p21 levels were markedly increased when the cells 
were treated for 24 and 48 hrs with both ½ IC50 and IC50 
concentrations (Fig. 4). The correlation between the 
upregulation of both p53 and p21 would strongly suggest a 
p53-dependent induction of p21 in these cells. Results suggest 
that MESBAD cytotoxicity and antiproliferative activity may 




Breast cancer is the most commonly diagnosed cancer in 
women both in the developed and less developed countries, 
with 18.1 million new cancer cases of cancer projected in 2018, 
female breast cancer was projected to be 11.6% (Bray et al., 
2018). Among females, breast cancer is the leading cause of 
cancer death (Bray et al., 2018; IARC, 2012; Azubuike et al., 
2018). Despite several therapeutic strategies, there is still 
limited success. Africa is blessed with abundant novel plant 
species with health-promoting compounds, many of which 
remain underutilized or undiscovered (Lamien-Meda et al., 
2008). The Baobab (Adansonia digitata L.) is one of such 
plants, it is widely distributed throughout the sub - Saharan 
Africa and Western Madagascar areas and has many uses, such 
as medicine, food, and beverages with all parts useful (Diop et 
al., 2006; Nouruddeen et al., 2014). An aqueous bark extract 
of A. digitata is traditionally used in Nigeria for treating sickle-
cell anemia, the same stem-bark is also considered beneficial 
as a heart tonic with diuretic properties (Ashorobi and Joda, 
1998). One of the widest uses in folk medicine is the use of the 
bark as a substitute for quinine in cases of fever or as a 
prophylactic (Wickens and Lowe, 2008). The many traditional 
uses of the stem bark of Adansonia digitata include among 
others, the treatment of cancer, for which there is very limited 
scientific data to validate its use. The current study describes 
the anti-cancer activity of MESBAD in human breast 
adenocarcinoma MCF-7 cells. The cytotoxic potential of 
MESBAD was investigated using MTT assay. The MTT is a 
yellow water soluble tetrazolium salt. A mitochondrial enzyme 
in living cells, succinate-dehydrogenase, cleaves the 
tetrazolium ring, converting the MTT to an insoluble purple 
formazan. Therefore, the amount of formazan produced is 
directly proportional to the number of viable cells (Mosmann, 
1983). The cytotoxicity/anticancer activity were recorded as 
concentration causing 50% growth inhibition (IC50) 
(Mosmann, 1983).  
 The MESBAD shows a dose dependent cytotoxic effect 
on MCF-7 cell line, after three consecutive experiments. The 
higher the concentration of MESBAD, the higher the cytotoxic 
effect and vice versa, as shown by the intensity of the purple 
formazan formed after the addition of the MTT salt to the cells. 
This experiment revealed that MESBAD possesses anticancer 
activity against MCF-7 cell line. In order to further establish 
the short-term cytotoxic effect of MESBAD, observed, 
clonogenic cell survival assay was employed to evaluate its 
long term antiproliferative potential on the cell line. The 
clonogenic cell survival assay determines the ability of a cell 
to proliferate indefinitely, thereby retaining its reproductive 
ability to form a large colony or a clone. The ability of a single 
cell to grow into a large colony, colonies are an indication that 
the cells have tumorigienicity; this is what is determined by the 
clonogenic assay. The MESBAD caused a clear reduction in 
the proliferation of human breast adenocarcinoma MCF-7 
Figure 3:  
p53 protein probe with 5% box milk PBS/T (MCF-
7). MESBAD induces p53 activation in a 
concentration dependent manner. Lane 1 was 
designated as vehicle control (0.1% DMSO), 2. 
IC50x2(24hrs), 3. IC50x2(48hrs), 4. IC50x4(24hrs), 
5. IC50x4(48hrs). 
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cells, when compared with the control that was treated with 
DMSO. The antiproliferative activity is also dose dependent as 
seen in the number of colonies present in the cells treated with 
½ IC50 and IC50. In order to be sure of the reproducibility of the 
observed effect, multiples of the IC50 were used to assess the 
possibility of complete disappearance of colonies. The result 
presented a similar pattern as the first set of results, with the 
cells treated with 4xIC50 having very scanty colonies. 
MESBAD shows a dose dependent long term antiproliferative 
effect on human breast adenocarcinoma MCF-7 cells. The 
result is in agreement with the earlier study of Elsaid et al. 
(2013), which demonstrated that the extracts of seeds and fruit 
pulp of Adansonia digitata L possess anti-tumor action and 
attenuated the p53 and Bcl-2 gene expression as pro-apoptic 
and anti-apoptic genes leading to management of tumor 
growth.  
 The mechanism by which MESBAD exerts its cytotoxic 
activity was therefore the next investigation. The expression 
patterns of certain apoptotic markers (p53 and p21) were 
examined. The most commonly mutated gene in human 
cancers is the p53 and over 50% of human cancers contain 
mutated form of p53, it is very useful as a therapeutic target for 
anticancer drug discovery (George, 2011). p21, a well-
established cyclin-dependent kinase (cdk) inhibitor, was found 
to play an important role in controlling cell cycle progression; 
p21 induction can also lead to a cell cycle arrest (Harper et al., 
1993). p21 was introduced as a tumor suppressor in brain, lung, 
and colon cancer cells; it was shown that p21 induces tumor 
growth suppression through wild type p53 activity (El-Deiry et 
al., 1993; Shamloo and Usluer, 2019). There is a relationship 
between p21 expression and mutation of the p53 tumor 
suppressor gene in normal and malignant ovarian epithelial 
cells. In many cell types, p53-mediated growth inhibition is 
dependent on induction of p21. There was a robust p53 
response in human breast adenocarcinoma MCF-7 cells treated 
with MESBAD, which in general correlated with an increase 
in levels of the cell cycle regulator p21. p53 levels were 
markedly increased at 24 and 48 hrs in the 2xIC50 treated cells 
while their p21 levels were also increased at 24 hrs and 48 hrs 
of ½IC50 and at IC50 both at 24 and 48 hrs treatment, suggesting 
a p53 dependent induction of p21 in these cells. These suggest 
that MESBAD may bring about a p53 dependent apoptosis. 
The results suggest that the anticancer activity of MESBAD 
may be p53 dependent, owing to its up-regulation. MESBAD 
also up-regulated the expression of p21 which is an early 
apoptotic response suggesting the possible role of p21 in the 
anticancer activity of MESBAD. Further experiments would 
be carried out on the effect of MESBAD on other anti-cancer 
modulatory genes and the isolation and characterization of the 
active principles. 
 In conclusion, the MESBAD is shown to induce cytotoxic 
and antiproliferative activities which are mediated by the p53 
and p21 responses. This study provides evidence that 
MESBAD is a potential anticancer and antiproliferative agent 
against oestrogen receptor positive human breast 
adenocarcinoma MCF-7 cells.  
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